JP2006516273A5 - - Google Patents

Download PDF

Info

Publication number
JP2006516273A5
JP2006516273A5 JP2006500200A JP2006500200A JP2006516273A5 JP 2006516273 A5 JP2006516273 A5 JP 2006516273A5 JP 2006500200 A JP2006500200 A JP 2006500200A JP 2006500200 A JP2006500200 A JP 2006500200A JP 2006516273 A5 JP2006516273 A5 JP 2006516273A5
Authority
JP
Japan
Prior art keywords
alkyl
optionally
further optionally
cycloalkyl
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006500200A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006516273A (ja
JP4688785B2 (ja
Filing date
Publication date
Priority claimed from SE0300092A external-priority patent/SE0300092D0/xx
Application filed filed Critical
Publication of JP2006516273A publication Critical patent/JP2006516273A/ja
Publication of JP2006516273A5 publication Critical patent/JP2006516273A5/ja
Application granted granted Critical
Publication of JP4688785B2 publication Critical patent/JP4688785B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006500200A 2003-01-15 2004-01-13 チオフェン−カルボキサミド誘導体および酵素ikk−2インヒビターとしてのその使用 Expired - Fee Related JP4688785B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0300092-4 2003-01-15
SE0300092A SE0300092D0 (sv) 2003-01-15 2003-01-15 Novel compounds
PCT/GB2004/000096 WO2004063186A1 (en) 2003-01-15 2004-01-13 Thiophene-carboxamide derivatives and their use as inhibitors of the enzime ikk-2

Publications (3)

Publication Number Publication Date
JP2006516273A JP2006516273A (ja) 2006-06-29
JP2006516273A5 true JP2006516273A5 (https=) 2007-02-22
JP4688785B2 JP4688785B2 (ja) 2011-05-25

Family

ID=20290127

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006500200A Expired - Fee Related JP4688785B2 (ja) 2003-01-15 2004-01-13 チオフェン−カルボキサミド誘導体および酵素ikk−2インヒビターとしてのその使用

Country Status (5)

Country Link
US (2) US7572826B2 (https=)
EP (1) EP1583755A1 (https=)
JP (1) JP4688785B2 (https=)
SE (1) SE0300092D0 (https=)
WO (1) WO2004063186A1 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0102616D0 (sv) * 2001-07-25 2001-07-25 Astrazeneca Ab Novel compounds
SE0300092D0 (sv) * 2003-01-15 2003-01-15 Astrazeneca Ab Novel compounds
SE0300091D0 (sv) 2003-01-15 2003-01-15 Astrazeneca Ab Novel compounds
BRPI0418351A (pt) * 2004-01-05 2007-05-08 Astrazeneca Ab composto ou um sal farmaceuticamente aceitável do mesmo, métodos de limitar a proliferação celular em um humano ou animal, de tratamento de um humano ou animal sofrendo de cáncer, de tratamento de profilaxia de cáncer, de tratamento de um humano ou animal sofrendo de uma doença neoplásica, de tratamento de um humano ou animal sofrendo de uma doença prolifetativa de tratamento de cáncer, para o tratamento de infecções associadas com cáncer, para o tratamento profilático de infecções associadas com cáncer, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, método de inibir a chk1 quinase, e, processo para a preparação de um composto ou um sal farmaceuticamente aceitável do mesmo
WO2005105777A1 (en) * 2004-05-05 2005-11-10 Pharmacia & Upjohn Company Llc Substituted thiophene amide compounds for the treatment of inflammation
US20060188445A1 (en) * 2005-02-22 2006-08-24 Fred Hutchinson Cancer Research Center Assay for compounds that protect against sensory hair cell death and compounds identified by same
ATE524454T1 (de) * 2006-11-01 2011-09-15 Chroma Therapeutics Ltd Inhibitoren von ikk-beta serinthreoninproteinkinase
EA200900616A1 (ru) 2006-11-01 2010-04-30 Хрома Терапьютикс Лтд. Ингибиторы ikk-бета серин-треонин протеинкиназы
CA2674865A1 (en) * 2007-01-15 2008-07-24 Santen Pharmaceutical Co., Ltd. Indole derivative having i.kappa.b kinase .beta. inhibitory activity
ES2395581T3 (es) * 2007-06-20 2013-02-13 Merck Sharp & Dohme Corp. Inhibidores de quinasas janus
JPWO2009096198A1 (ja) * 2008-02-01 2011-05-26 一般社団法人ファルマIp 新規ビアリール誘導体
JP2011518817A (ja) * 2008-04-26 2011-06-30 クロマ セラピューティクス リミテッド IKK−βセリン−、スレオニン−プロテインキナーゼ阻害剤としての置換されたチオフェンカルボキシアミド類
US8445529B2 (en) * 2008-07-14 2013-05-21 Santen Pharmaceutical Co., Ltd. Indole derivative having, carbamoyl group, ureido group and substituted oxy group
GB0913345D0 (en) 2009-07-31 2009-09-16 Astrazeneca Ab New combination 802
WO2011061527A1 (en) 2009-11-17 2011-05-26 Astrazeneca Ab Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases
US20110135756A1 (en) * 2009-12-08 2011-06-09 University Of Washington Compositions and methods for protecting sensory hair cells
GB201016912D0 (en) 2010-10-07 2010-11-24 Astrazeneca Ab Novel combination
GB201021979D0 (en) 2010-12-23 2011-02-02 Astrazeneca Ab New compound

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1098240A (en) * 1903-01-23 1914-05-26 United Shoe Machinery Ab Skiving-machine.
US1084171A (en) * 1910-09-13 1914-01-13 New York Attachable Player Action Co Player-piano.
GB1468012A (en) 1973-08-09 1977-03-23 Beecham Group Ltd 2-amino-3-carboxy-thiophene derivatives
DE3529247A1 (de) 1985-05-17 1986-11-20 Bayer Ag, 5090 Leverkusen Verwendung von thienylharnstoffen und -isoharnstoffen als leistungsfoerdernde mittel bei tieren, neue thienylharnstoffe und -isoharnstoffe und ihre herstellung
GB2195634B (en) 1986-10-01 1990-08-15 Roussel Lab Ltd Thiophene derivatives
US5258357A (en) * 1989-10-07 1993-11-02 Basf Aktiengesellschaft Carboxamides, their preparation and their use as herbicides
US5378703A (en) * 1990-04-09 1995-01-03 Alcon Laboratories, Inc. Sulfonamides useful as carbonic anhydrase inhibitors
US5571810A (en) * 1990-06-11 1996-11-05 Fujisawa Pharmaceutical Co., Ltd. Thiophene derivatives
US5514801A (en) * 1992-12-29 1996-05-07 Monsanto Company Cyclic sulfone containing retroviral protease inhibitors
BR9710352A (pt) 1996-07-11 1999-08-17 Pfizer Compostos piridilpirrole
PT853083E (pt) 1997-01-06 2001-12-28 Pfizer Composto de piridilfurano e piridiltiofeno e sua utilizacao farmaceutica
US6809088B2 (en) * 1997-03-24 2004-10-26 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
US6117911A (en) 1997-04-11 2000-09-12 Neorx Corporation Compounds and therapies for the prevention of vascular and non-vascular pathologies
US6037340A (en) 1997-05-28 2000-03-14 Cadus Pharmaceutical Corporation Synthesis and use of thiophene- and pyrrole-based heteroaromatic compounds
DE19744026A1 (de) 1997-10-06 1999-04-08 Hoechst Marion Roussel De Gmbh Pyrazol-Derivate, ihre Herstellung und ihre Verwendung in Arzneimitteln
AU2713799A (en) 1998-03-12 1999-09-27 Novo Nordisk A/S Modulators of protein tyrosine phosphatases (ptpases)
CN1332943C (zh) * 1998-07-08 2007-08-22 萨诺费-阿文蒂斯德国有限公司 硫取代的磺酰基氨基羧酸n-芳基酰胺,其制备方法、用途以及含有该化合物的药物制剂
HK1045312A1 (zh) * 1999-01-07 2002-11-22 藤泽药品工业株式会社 環狀化合物
HN2000000051A (es) 1999-05-19 2001-02-02 Pfizer Prod Inc Derivados heterociclicos utiles como agentes anticancerosos
GB0003154D0 (en) * 2000-02-12 2000-04-05 Astrazeneca Uk Ltd Novel compounds
EP1274705A1 (en) * 2000-03-29 2003-01-15 Cyclacel Limited 2-substituted 4-heteroaryl-pyrimidines and their use in the treatment of proliferative disorders
US6414013B1 (en) * 2000-06-19 2002-07-02 Pharmacia & Upjohn S.P.A. Thiophene compounds, process for preparing the same, and pharmaceutical compositions containing the same background of the invention
DE10034624A1 (de) * 2000-07-17 2002-01-31 Bayer Ag Aryl-substituierte Thienyl-1,3-oxazolidin-2-one als Cytokin-Inhibitoren
EP1324759A4 (en) 2000-10-12 2004-05-12 Smithkline Beecham Corp NF - G (K) B INHIBITORS
US7122544B2 (en) 2000-12-06 2006-10-17 Signal Pharmaceuticals, Llc Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto
US6713638B2 (en) * 2001-05-18 2004-03-30 Joel M. Linden 2-amino-3-aroyl-4,5 alkylthiophenes: agonist allosteric enhancers at human A1 adenosine receptors
CN101624391A (zh) * 2001-06-11 2010-01-13 病毒化学医药公司 用作黄病毒感染抗病毒剂的噻吩衍生物
SE0102616D0 (sv) 2001-07-25 2001-07-25 Astrazeneca Ab Novel compounds
SE0102617D0 (sv) 2001-07-25 2001-07-25 Astrazeneca Ab Novel compounds
WO2003029241A1 (en) 2001-10-04 2003-04-10 Smithkline Beecham Corporation Chk1 kinase inhibitors
WO2003028731A1 (en) 2001-10-04 2003-04-10 Smithkline Beecham Corporation Chk1 kinase inhibitors
DE60229975D1 (de) * 2001-10-04 2009-01-02 Smithkline Beecham Corp Nf-kb-inhibitoren
TWI281916B (en) * 2001-10-25 2007-06-01 Lilly Co Eli Antitumor compounds and methods
US6835745B2 (en) * 2002-01-15 2004-12-28 Wyeth Phenyl substituted thiophenes as estrogenic agents
US7196106B2 (en) * 2002-11-05 2007-03-27 Merck & Co., Inc Cyanothiophene derivatives, compositions containing such compounds and methods of use
SE0300091D0 (sv) * 2003-01-15 2003-01-15 Astrazeneca Ab Novel compounds
SE0300092D0 (sv) 2003-01-15 2003-01-15 Astrazeneca Ab Novel compounds
US7572868B2 (en) * 2003-08-27 2009-08-11 Ciba Specialty Chemicals Corp. Composition and process for the controlled synthesis of block copolymers
BRPI0418351A (pt) * 2004-01-05 2007-05-08 Astrazeneca Ab composto ou um sal farmaceuticamente aceitável do mesmo, métodos de limitar a proliferação celular em um humano ou animal, de tratamento de um humano ou animal sofrendo de cáncer, de tratamento de profilaxia de cáncer, de tratamento de um humano ou animal sofrendo de uma doença neoplásica, de tratamento de um humano ou animal sofrendo de uma doença prolifetativa de tratamento de cáncer, para o tratamento de infecções associadas com cáncer, para o tratamento profilático de infecções associadas com cáncer, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, método de inibir a chk1 quinase, e, processo para a preparação de um composto ou um sal farmaceuticamente aceitável do mesmo

Similar Documents

Publication Publication Date Title
JP2006516273A5 (https=)
JP2010528089A5 (https=)
AR063946A1 (es) Determinadas pirimidinas sustituidas, el uso de las mismas para el tratamiento de enfermedades mediadas por la inhibicion de la actividad de btk y composiciones farmaceuticas que las comprenden.
Li et al. Catalytic enantioselective addition of alcohols to isatin-derived N-Boc ketimines
EA200602290A1 (ru) Лиганды crth2 рецептора и их применение
HRP20140201T1 (hr) Kondenzirani cikliäśki spojevi kao modulatori gpr40-receptora
HRP20120447T1 (hr) 5-supstituirani derivati kinazolinona kao protutumorska sredstva
JP2013509392A5 (https=)
AR040351A1 (es) Derivados de quinuclidina-amida, composicion farmaceutica, procedimiento de preparacion del compuesto y su uso para fabricar medicamentos
EA200600527A1 (ru) Активирующее ppar соединение и содержащая его фармацевтическая композиция
RS65642B1 (sr) Supstituisani pirazolo(1,5-a)pirimidini i njihova upotreba u lečenju medicinskih poremećaja
JPS58185553A (ja) α−保護されたオキシイミノ−β−ケト−γ−ハロゲノ酪酸類
AR043679A1 (es) Derivados de acetil 2-hidroxi-1,3-diaminoalcanos, metodos de preparacion de los mismos y su uso en la fabricacion de medicamentos para el tratamiento o prevencion del mal de alzheimer
HRP20140723T1 (hr) Postupak za proizvodnju rosuvastatina
HRP20151439T1 (hr) Halogenirani derivati benzamida
NO20082226L (no) 6-heteroarylpyridoindolonderivater, deres fremstilling og terapeutisk anvendelse derav
CN104262309B (zh) 一种色酮类衍生物及其合成方法
WO2001062708A1 (fr) Derives d'acide benzoique, procede de production desdits derives, et medicament contenant ces derives comme principe actif
ES2602962T3 (es) Derivado de fenilazol sustituido
Datta et al. A stereoselective route to hydroxyethylamine dipeptide isosteres
FR2891825A1 (fr) Derives de la 1-amino-isoquinoline, leur preparation et leur application en therapeutique
CA2354605A1 (en) Diazabicyclooctane derivatives and therapeutic uses thereof
CN109251192A (zh) 3位或4位三氟甲基取代异香豆素的制备方法
CN104610037A (zh) β-三氟甲基-β-羟基酮的制备方法
HRP20161485T1 (hr) Polimorfna forma n-[4-(trifluorometil)benzil)-4-metoksibutiramida